Sanofi-GSK next-generation COVID-19 booster delivers strong immune response against variants of concern, including Omicron
Next-generation booster vaccine candidate delivers immune boost in adults primed with mRNA vaccines; with a stronger immune response compared to Pfizer-BioNTech’s Comirnaty booster vaccine
Next-generation booster vaccine candidate demonstrates potential to protect against COVID-19 variants of concern, including Omicron BA.1 and BA.2, with a favorable safety and tolerability profile
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.